1611602882330.jpg
Invizyne Technologies Announces Filing of Registration Statement for Proposed Offering and Listing on Nasdaq
February 12, 2024 08:00 ET | Invizyne Technologies, Inc.
Monrovia, CA, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB Capital Holdings, LLC,...
1611602882330.jpg
Michael Burns Joins Invizyne as Executive Vice President of Energy Transition
November 08, 2023 16:05 ET | Invizyne Technologies, Inc.
Monrovia, CA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB Capital Holdings, LLC,...
1611602882330.jpg
Invizyne Selected by Shell GameChanger Accelerator Powered by NREL for Sixth Cohort
October 17, 2023 10:00 ET | Invizyne Technologies, Inc.
Monrovia, CA, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB Capital Holdings, LLC,...
1611602882330.jpg
Invizyne Awarded Additional $3.77 Million Grant from U.S. Department of Energy
October 11, 2023 11:10 ET | Invizyne Technologies, Inc.
Monrovia, CA, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a “Big Idea” company from MDB Capital Holdings, LLC,...